Compagnie Lombard Odier S Cm A Ac Immune Sa Transaction History

Compagnie Lombard Odier S Cm A

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 16, 2025	SELL	$1.87 - $2.98 $18,700 - $29,800	-10,000 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$4.83 - $7.56 $9,660 - $15,120	-2,000 Reduced 16.67%	10,000 $49,000
Q2 2021 Jul 15, 2021	SELL	$6.04 - $8.37 $1.29 Million - $1.79 Million	-213,359 Reduced 94.68%	12,000 $96,000
Q1 2021 Apr 23, 2021	BUY	$5.32 - $8.96 $1.11 Million - $1.87 Million	208,359 Added 1225.64%	225,359 $1.72 Million
Q3 2020 Nov 12, 2020	SELL	$4.78 - $9.06 $14,340 - $27,180	-3,000 Reduced 15.0%	17,000 $83,000
Q1 2020 May 13, 2020	SELL	$4.24 - $9.89 $16,960 - $39,560	-4,000 Reduced 16.67%	20,000 $138,000
Q4 2019 Feb 13, 2020	SELL	$4.56 - $8.78 $52,617 - $101,312	-11,539 Reduced 32.47%	24,000 $204,000
Q1 2019 May 13, 2019	BUY	$3.65 - $11.68 $39,055 - $124,976	10,700 Added 43.08%	35,539 $180,000
Q4 2018 Feb 13, 2019	SELL	$7.35 - $11.7 $63,945 - $101,790	-8,700 Reduced 25.94%	24,839 $236,000
Q3 2018 Nov 13, 2018	BUY	$7.88 - $16.45 $236,707 - $494,141	30,039 Added 858.26%	33,539 $268,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,500	3,500 $31,000

26.8M

94.9K

22.5K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $276M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.